Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Recombinant Human Leptin (METRELEPTIN) in Various Forms of Partial Lipodystrophy

NCT02654977 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT02654977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02654977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Recombinant Human Leptin (METRELEPTIN) in Various Forms of Partial Lipodystrophy
Lead sponsor
University of Michigan
Phase
Phase 2
Overall status
Completed
Start date
September 29, 2015
Completion date
November 14, 2019
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial partial lipodystrophy, nafld, nonalcoholic steatohepatitis